{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T04:26:34Z","timestamp":1784435194646,"version":"3.55.0"},"reference-count":26,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Cardiology, Warsaw, Poland","award":["4.44\/VII\/24"],"award-info":[{"award-number":["4.44\/VII\/24"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives:\u00a0PRKAG2 syndrome (PS) is a rare genocopy of hypertrophic cardiomyopathy (HCM). Our goal was to expand knowledge about PS by analyzing patient clinical, imaging, and follow-up data. Methods: The study included carriers of likely pathogenic or pathogenic PRKAG2 variants identified in the years 2011\u20132022. Cardiac involvement was assessed by electrocardiography, echocardiography, cardiac magnetic resonance imaging, and endomyocardial biopsy (EMB). We recorded concomitant diseases and cardiac events, including the implantation of electronic cardiac devices, arrhythmia, heart failure (HF), and death. Results: Seven patients from four families (median age 43 years) with PRKAG2 variants: Phe293Leu, Val336Leu, Arg302Gln, and His530Arg were included. At the first evaluation, 3 carriers were in New York Heart Association (NYHA) functional class II\u2013III, while the remaining were in NYHA class I. Left ventricular hypertrophy (LVH) was present in 5 patients; 2 had ventricular pre-excitation, one was in atrial flutter and pacemaker-dependent; 2 had bradycardia. Two female carriers had concomitant chronic renal disease. In the EMB of one of the patients, staining for glycogen deposits was positive. Furthermore, we provide a link between the Val336Leu PRKAG2 variant and autophagy identified on EMB. After a median follow-up of 13.1 years, 6 carriers had LVH, 3 required admission for HF, and 1 had sustained ventricular tachycardia with subsequent cardioverter defibrillator implantation, and despite this, died suddenly; there were two de novo pacemaker implantations due to symptomatic bradycardia. Conclusions: PR is a distinctive disorder with an early onset of arrhythmic events, often leading to HF.<\/jats:p>","DOI":"10.3390\/biomedicines13030751","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T09:17:39Z","timestamp":1742462259000},"page":"751","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PRKAG2 Syndrome: Clinical Features, Imaging Findings and Cardiac Events"],"prefix":"10.3390","volume":"13","author":[{"given":"Maria","family":"Sudomir","sequence":"first","affiliation":[{"name":"Unit for Screening Studies in Inherited Cardiovascular Diseases, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6655-0070","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Chmielewski","sequence":"additional","affiliation":[{"name":"Unit for Screening Studies in Inherited Cardiovascular Diseases, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-5145","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Truszkowska","sequence":"additional","affiliation":[{"name":"Molecular Biology Laboratory, Department of Medical Biology, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"K\u0142opotowski","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Interventional Angiology, National Institute of Cardiology, 04-628 Warsaw, Poland"},{"name":"Cardiomyopathy Outpatient Clinic, Cardiac Arrhythmia Center, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2393-4194","authenticated-orcid":false,"given":"Mateusz","family":"\u015apiewak","sequence":"additional","affiliation":[{"name":"Magnetic Resonance Unit, Department of Radiology, National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6571-6375","authenticated-orcid":false,"given":"Marta","family":"Legatowicz-Koprowska","sequence":"additional","affiliation":[{"name":"Department of Pathomorphology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gawor-Prokopczyk","sequence":"additional","affiliation":[{"name":"Department of Cardiomyopathy, National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Szczygie\u0142","sequence":"additional","affiliation":[{"name":"Department of Cardiomyopathy, National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Zakrzewska-Koperska","sequence":"additional","affiliation":[{"name":"1st Department of Arrhythmia, National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Kruk","sequence":"additional","affiliation":[{"name":"Coronary Artery and Structural Diseases Department, National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-6178","authenticated-orcid":false,"given":"Jolanta","family":"Krzyszto\u0144-Russjan","sequence":"additional","affiliation":[{"name":"Molecular Biology Laboratory, Department of Medical Biology, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Grzybowski","sequence":"additional","affiliation":[{"name":"Department of Cardiomyopathy, National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"P\u0142oski","sequence":"additional","affiliation":[{"name":"Molecular Biology Laboratory, Department of Medical Biology, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warsaw, Poland"},{"name":"Department of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1451-2069","authenticated-orcid":false,"given":"Zofia T.","family":"Bili\u0144ska","sequence":"additional","affiliation":[{"name":"Unit for Screening Studies in Inherited Cardiovascular Diseases, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM200106143442403","article-title":"Identification of a gene responsible for familial Wolff-Parkinson-White syndrome","volume":"344","author":"Gollob","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy","volume":"109","author":"Arad","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2004.11.053","article-title":"Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: Natural history","volume":"45","author":"Murphy","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1161\/hc5001.102111","article-title":"Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy","volume":"104","author":"Gollob","year":"2001","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gerull, B., Klaassen, S., and Brodehl, A. (2020). The Genetic Landscape of Cardiomyopathies. Genetic Causes of Cardiac Disease, Springer Nature.","DOI":"10.1007\/978-3-030-27371-2_2"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13148-023-01591-w","article-title":"Abnormal expression of PRKAG2-AS results in dysfunction of cardiomyocytes through regulating PRKAG2 transcription by interacting with PPARG","volume":"15","author":"Song","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacc.2020.05.029","article-title":"Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis","volume":"76","author":"Dominguez","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/978-1-4939-7598-3_37","article-title":"Human \u03b32-AMPK Mutations","volume":"1732","author":"Yavari","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jmicro\/dfp048","article-title":"Autophagy in transition from hypertrophic cardiomyopathy to heart failure","volume":"59","author":"Walczak","year":"2010","journal-title":"J. Electron. Microsc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41431-023-01421-w","article-title":"EMQN: Recommendations for genetic testing in inherited cardiomyopathies and arrhythmias","volume":"31","author":"Hayesmoore","year":"2023","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/ehf2.13914","article-title":"Hypokinetic hypertrophic cardiomyopathy: Clinical phenotype, genetics, and prognosis","volume":"9","author":"Wasserstrum","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/ehf2.12925","article-title":"ESC EORP Cardiomyopathy Registry: Real-life practice of genetic counselling and testing in adult cardiomyopathy patients","volume":"7","author":"Elliott","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_17","first-page":"651","article-title":"High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations","volume":"19","author":"Thevenon","year":"2017","journal-title":"Europace"},{"key":"ref_18","first-page":"16850","article-title":"Progression of interstitial fibrosis in apical segments in hypertrophic cardiomyopathy: A longitudinal magnetic resonance study","volume":"134","year":"2024","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_19","first-page":"1227","article-title":"Clinical features, etiology, and survival in patients with restrictive cardiomyopathy: A single-center experience","volume":"81","author":"Truszkowska","year":"2023","journal-title":"Kardiol. Pol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yang, K.Q., Lu, C.X., Zhang, Y., Yang, Y.K., Li, J.C., Lan, T., Meng, X., Fan, P., Tian, T., and Wang, L.P. (2017). A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-02455-z"},{"key":"ref_21","first-page":"16603","article-title":"Microvascular dysfunction in hypertrophic cardiomyopathy: Diagnostic role of noninvasive, fully automated quantitative perfusion cardiovascular magnetic resonance imaging","volume":"134","year":"2024","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"976","DOI":"10.33963\/v.phj.102044","article-title":"Exploring the link between myocardial bridging and left ventricular hypertrophy: Congenital factors or remodelling?","volume":"82","author":"Acar","year":"2024","journal-title":"Kardiol. Pol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1161\/CIRCULATIONAHA.105.550806","article-title":"Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy","volume":"112","author":"Ahmad","year":"2005","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eux238","article-title":"High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations: Comment","volume":"20","author":"Qiu","year":"2018","journal-title":"Europace"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1086\/430840","article-title":"Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency","volume":"76","author":"Burwinkel","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e003121","DOI":"10.1161\/CIRCEP.115.003121","article-title":"Clinical Spectrum of PRKAG2 Syndrome","volume":"9","author":"Porto","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/3\/751\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:56:45Z","timestamp":1760029005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/3\/751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["biomedicines13030751"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13030751","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}